Funding for Global Cancer Research and Training
The Center for Global Health (CGH) funds research to reduce the global burden of cancer and offers research training opportunities for investigators to strengthen their research abilities.
Sort the table below for current funding opportunities for global cancer research and research training.
Learn more about grants and funding from the National Institutes of Health.
Current Funding Opportunities
|Title||Announcement Number||Opening Date||Expiration Date||Additional Resources|
|Notice of Special Interest (NOSI): Precision Imaging of Oral Lesions||NOT-DE-21-010||08/06/2021||09/10/2024|
|Mobile Health: Technology and Outcomes in Low- and Middle-Income Countries (R21/R33 - Clinical Trial Optional)||PAR-21-303||08/04/2021||12/10/2022|
|SBIR Contract Topic 440 - Cancer Prevention and Diagnosis Technologies for Low-resource Settings (with HPV Dx set aside)||NIH/NCI 440||Receipt date: October 28, 2021, 5:00 p.m. EST|
|Notice of Special Interest (NOSI): National Cancer Institute SBIR/STTR Program Announcement Regarding Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings||NOT-CA-21-062||07/23/2021||09/07/2024||This funding opportunity is part of a broader NCI-sponsored Affordable Cancer Technologies (ACTs) Program.|
|Implementation Science for Cancer Control in People Living with HIV in Low- and Middle-Income Countries (U01 Clinical Trial Optional)||RFA-CA-21-056||08/25/2021||12/16/2021|
|Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional)||RFA-CA-21-030||02/18/2021||06/03/2021||This funding opportunity is part of a broader NCI-sponsored Affordable Cancer Technologies (ACTs) Program.|
|Strengthening Institutional Capacity to Conduct Global Cancer Research in Low- and Middle-Income Countries (D43 Clinical Trial Not Allowed)||RFA-CA-20-031||04/14/2020||06/25/2021||D43 Pre-Application Webinar Slides
RFA-CA-20-031 Frequently Asked Questions
|International Research Scientist Development Award (IRSDA) (K01) Independent Clinical Trial Not Allowed||PAR-21-104||01/04/2021||03/09/2023|
|International Research Scientist Development Award (IRSDA) (K01 Independent Clinical Trial Required)||PAR-21-105||01/04/2021||03/09/2023|
|The East Asia Science and Innovation Area Joint Research Program||e-ASIA JRP call for applications||Solicitation Guidelines|
|Notice of Special Interest (NOSI): Innovative Molecular Analysis Technologies for Low-Resource Settings Globally||NOT-CA-21-025||01/04/2020||09/30/2021|
|Notice of Special Interest: Academy of Finland (AKA) – National Institutes of Health (NIH) Partnership Program||NOT-OD-21-021||11/13/2020|
|Notice of Special Interest (NOSI): Advancing Head and Neck Cancer Early Detection Research (AHEAD)||NOT-CA-20-031||03/09/2020||01/08/2022|
|Notice of Special Interest (NOSI): Dissemination and Implementation Science for Cancer Prevention and Control in Low Resource Environments||NOT-CA-20-025||02/10/2020||05/08/2022||Interested applicants must submit applications for this initiative using one of the following Dissemination and Implementation Research in Health FOAs:|
|Microbial-based Cancer Therapy - Bugs as Drugs (R21 Clinical Trial Not Allowed)||PAR-19-194||05/16/2019||05/08/2022||Microbial-based Cancer Therapy - Technologies to Overcome Cancer|
|Microbial-based Cancer Therapy -Bugs as Drugs (R01 Clinical Trial Not Allowed)||PAR-19-193||05/05/2019||05/08/2022||Microbial-based Cancer Therapy - Technologies to Overcome Cancer|
|Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)||PAR-19-274||05/08/2019||05/08/2022|
|Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)||PAR-19-275||05/16/2019||05/08/2022|
|Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)||PAR-19-276||05/16/2019||05/08/2022|
Explore cancer research programs and research training offered and funded through CGH.